Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SAMUEL M FREEDMAN

Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology

NPI
1588701379
CMS profile
71539
Location
PEMBROKE PINES, FL

General Payments · PY2018–2024

$96,810.39

  • Reported across 171 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$5,515.88

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
BioMarin Pharmaceutical Inc. $5,350.00 2
ABBVIE INC. $134.62 10
Novo Nordisk AS $31.26 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $29,129.26 42
PY2019 $15,055.86 44
PY2020 $24,166.32 29
PY2021 $14,429.93 18
PY2022 $4,321.14 12
PY2023 $4,192.00 12
PY2024 $5,515.88 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $16.04 01/08/2024 Food and Beverage Undisputed 01/23/2026 1103752427 CMS
ABBVIE INC. $16.27 05/07/2024 Food and Beverage Undisputed 01/23/2026 1103752429 CMS
ABBVIE INC. $23.71 07/01/2024 Food and Beverage Undisputed 01/23/2026 1103752431 CMS
ABBVIE INC. $10.00 07/16/2024 Food and Beverage Undisputed 01/23/2026 1103752433 CMS
ABBVIE INC. $3.62 07/16/2024 Food and Beverage Undisputed 01/23/2026 1103752435 CMS
ABBVIE INC. $11.84 09/25/2024 Food and Beverage Undisputed 01/23/2026 1103752437 CMS
ABBVIE INC. $16.76 09/25/2024 Food and Beverage Undisputed 01/23/2026 1103752439 CMS
ABBVIE INC. $15.85 09/26/2024 Food and Beverage Undisputed 01/23/2026 1103752441 CMS
ABBVIE INC. $2.51 09/26/2024 Food and Beverage Undisputed 01/23/2026 1103752443 CMS
ABBVIE INC. $18.02 12/04/2024 Food and Beverage Undisputed 01/23/2026 1103752445 CMS
BioMarin Pharmaceutical Inc. $5,250.00 11/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1127058769 CMS
BioMarin Pharmaceutical Inc. $100.00 11/07/2024 Food and Beverage Undisputed 01/23/2026 1127059035 CMS
Novo Nordisk Inc $15.78 10/30/2024 Food and Beverage Undisputed 01/23/2026 1097278211 CMS
Novo Nordisk Inc $15.48 11/21/2024 Food and Beverage Undisputed 01/23/2026 1097373595 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.